Literature DB >> 14770433

Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.

Astrid N Scholten1, Vincent T H B M Smit, Henk Beerman, Wim L J van Putten, Carien L Creutzberg.   

Abstract

BACKGROUND: The most widely used histologic grading system for endometrial carcinoma is the three-tiered International Federation of Gynecology and Obstetrics (FIGO) system. Although FIGO grading has significant predictive value, the reproducibility of Grade 2 is limited. Recently, a binary grading system was proposed based on the amount of solid growth, the pattern of myometrial invasion, and the presence of tumor cell necrosis. The authors analyzed and compared the prognostic significance and the interobserver variability of both grading systems and of the three criteria for the binary grading system.
METHODS: Eight hundred patients with Stage I-III endometrioid endometrial carcinoma were reviewed and graded independently by two pathologists according to the three-tiered FIGO grading system and the novel binary grading system.
RESULTS: The interobserver agreement for both systems was moderate, with 70% and 73% agreement rates for the FIGO (kappa = 0.41) and binary (kappa = 0.39) grading systems, respectively. When converting the FIGO grading system into an artificial, 2-tiered grading system (Grade 3 vs. Grades 1-2), the agreement was much better (agreement rate, 85%; kappa = 0.58). Of the 3 criteria for the binary grading system, amount of solid growth (< or = 50% vs. > 50%) had the greatest reproducibility (agreement rate, 80%; kappa = 0.50). Both the 2-tiered FIGO grading system and the binary grading system were significant predictors of local recurrence, distant recurrence, and disease-specific survival (hazard ratios [HRs]: 1.7, 2.5, and 2.6, respectively, for FIGO and 2.1, 4.1, and 3.8, respectively, for the binary grading system). The amount of solid growth also was a strong prognostic factor for these three endpoints (HRs: 2.4, 3.9, and 3.8, respectively).
CONCLUSIONS: Both the binary grading system and the FIGO grading system had strong prognostic significance. Their reproducibility, however, was limited. A simple architectural binary grading system that divided tumors into low-grade lesions and high-grade lesions based on the proportion of solid growth (< or = 50% or > 50%) had superior prognostic power and greater reproducibility. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 14770433     DOI: 10.1002/cncr.20040

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Interrater reliability of assessing levator ani muscle defects with magnetic resonance images.

Authors:  Daniel M Morgan; Wolfgang Umek; Tamara Stein; Yvonne Hsu; Kenneth Guire; John O L DeLancey
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-10-17

Review 2.  Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?

Authors:  S Marnitz; C Köhler; N Gharbi; S Kunze; K Jablonska; J Herter
Journal:  Strahlenther Onkol       Date:  2018-08-15       Impact factor: 3.621

3.  Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer.

Authors:  Taejong Song; Jeong-Won Lee; Chel Hun Choi; Tae-Joong Kim; Duk-Soo Bae; Chang Ohk Sung; Sang Yong Song; Byoung-Gie Kim
Journal:  Int J Clin Oncol       Date:  2011-10-13       Impact factor: 3.402

4.  Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.

Authors:  Serra Akar; Zeliha Esin Çelik; Sıddıka Fındık; Tolgay Tuyan İlhan; Fedi Ercan; Çetin Çelik
Journal:  Int J Clin Oncol       Date:  2019-08-26       Impact factor: 3.402

Review 5.  Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  W Glenn McCluggage; Meagan J Judge; Blaise A Clarke; Ben Davidson; C Blake Gilks; Harry Hollema; Jonathan A Ledermann; Xavier Matias-Guiu; Yoshiki Mikami; Colin J R Stewart; Russell Vang; Lynn Hirschowitz
Journal:  Mod Pathol       Date:  2015-06-19       Impact factor: 7.842

6.  Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.

Authors:  Laura M S Seeber; Nicole Horrée; Petra van der Groep; Elsken van der Wall; René H M Verheijen; Paul J van Diest
Journal:  BMC Cancer       Date:  2010-06-19       Impact factor: 4.430

7.  Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.

Authors:  Sumi Thomas; Yaser Hussein; Sudeshna Bandyopadhyay; Michele Cote; Oudai Hassan; Eman Abdulfatah; Baraa Alosh; Hui Guan; Robert A Soslow; Rouba Ali-Fehmi
Journal:  Arch Pathol Lab Med       Date:  2016-05-03       Impact factor: 5.534

Review 8.  [Grading of gynecological tumors : Current aspects].

Authors:  L-C Horn; D Mayr; C E Brambs; J Einenkel; I Sändig; K Schierle
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

9.  Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

Authors:  Ellen Stelloo; Tjalling Bosse; Remi A Nout; Helen J MacKay; David N Church; Hans W Nijman; Alexandra Leary; Richard J Edmondson; Melanie E Powell; Emma J Crosbie; Henry C Kitchener; Linda Mileshkin; Pamela M Pollock; Vincent T Smit; Carien L Creutzberg
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

10.  Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study.

Authors:  Sophia Scharl; Tim Sprötge; Michael Gerken; Anton Scharl; Atanas Ignatov; Elisabeth C Inwald; Olaf Ortmann; Oliver Kölbl; Monika Klinkhammer-Schalke; Thomas Papathemelis
Journal:  Arch Gynecol Obstet       Date:  2021-07-05       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.